Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

FDA conditionally approves first oral tablet to treat lymphoma in dogs

Reading Time: 2 minutes The U.S. Food and Drug Administration recently (Jan. 11) conditionally approved Laverdia-CA1 (verdinexor tablets) to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. According to a press release from the FDA, Laverdia-CA1 is the first conditionally approved oral treatment for dogs with lymphoma. Conditional approval allows veterinarians to...


This post first appeared on Wow My Pet Did That!, please read the originial post: here

Share the post

FDA conditionally approves first oral tablet to treat lymphoma in dogs

×

Subscribe to Wow My Pet Did That!

Get updates delivered right to your inbox!

Thank you for your subscription

×